Treatment of symtomatic benign prostatic hyperplasia to improve symtoms, reduce risk of accute urinary retension, and the risk of the need for surgery including transurenthral resection of the prostate and prostectomy. In combination with doxazosin to refucevrisk if symtomatic progression of benign prostatic hyperplasia.
ขนาดที่ใช้: 5 มก. ต่อวัน
A:
CI: Women &chrildren. Pregnancy (or may potentially be pregnant). Hypersensitivity to any component of this product.
Sp: Lastvresifual urine vol & / or severely diminished urinary flow (monitor for obstructive utopathy); prostate cancer evaluation ( initial and periodic digital rectal exam). Women sjould not handle crushed or broken tablets when they are or may potentially be pregnant. Lactation. Children.
AR: Impotence; decreased libido & vol of ejaculate; ejaculation disorder; breast enlargement andvtenderness, rash.
PP: Tab 5 mg. X 30's (Bht 1,426.31)